As of 2025-11-14, the Relative Valuation of Akero Therapeutics Inc (AKRO) is (57.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.20 USD, the upside of Akero Therapeutics Inc based on Relative Valuation is -206.2%.
The range of the Relative Valuation is (57.60) - (70.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 20.0x | 16.2x |
| Forward P/E multiples | 16.3x - 24.5x | 16.3x |
| Fair Price | (57.60) - (70.99) | (57.56) |
| Upside | -206.3% - -231.0% | -206.2% |
| Date | P/E |
| 2025-11-13 | -15.31 |
| 2025-11-12 | -15.33 |
| 2025-11-11 | -15.31 |
| 2025-11-10 | -15.28 |
| 2025-11-07 | -15.26 |
| 2025-11-06 | -15.22 |
| 2025-11-05 | -15.26 |
| 2025-11-04 | -15.25 |
| 2025-11-03 | -15.27 |
| 2025-10-31 | -15.30 |
| 2025-10-30 | -15.32 |
| 2025-10-29 | -15.24 |
| 2025-10-28 | -15.24 |
| 2025-10-27 | -15.20 |
| 2025-10-24 | -15.18 |
| 2025-10-23 | -15.16 |
| 2025-10-22 | -15.13 |
| 2025-10-21 | -15.19 |
| 2025-10-20 | -15.22 |
| 2025-10-17 | -15.20 |
| 2025-10-16 | -15.15 |
| 2025-10-15 | -15.13 |
| 2025-10-14 | -15.19 |
| 2025-10-13 | -15.15 |
| 2025-10-10 | -15.21 |
| 2025-10-09 | -15.27 |
| 2025-10-08 | -13.12 |
| 2025-10-07 | -12.99 |
| 2025-10-06 | -13.00 |
| 2025-10-03 | -13.01 |
| 2025-10-02 | -13.10 |
| 2025-10-01 | -13.14 |
| 2025-09-30 | -13.40 |
| 2025-09-29 | -13.44 |
| 2025-09-26 | -13.48 |
| 2025-09-25 | -13.05 |
| 2025-09-24 | -13.40 |
| 2025-09-23 | -13.50 |
| 2025-09-22 | -13.10 |
| 2025-09-19 | -12.77 |
| 2025-09-18 | -13.04 |
| 2025-09-17 | -11.91 |
| 2025-09-16 | -12.03 |
| 2025-09-15 | -12.10 |
| 2025-09-12 | -12.27 |
| 2025-09-11 | -12.68 |
| 2025-09-10 | -12.21 |
| 2025-09-09 | -12.60 |
| 2025-09-08 | -12.58 |
| 2025-09-05 | -12.62 |